Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Exchange Rate Effect (2020 - 2025)

Historic Exchange Rate Effect for BioNexus Gene Lab (BGLC) over the last 6 years, with Q3 2025 value amounting to $28535.0.

  • BioNexus Gene Lab's Exchange Rate Effect fell 9495.24% to $28535.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$122796.0, marking a year-over-year decrease of 12471.05%. This contributed to the annual value of $40339.0 for FY2024, which is 11553.42% up from last year.
  • According to the latest figures from Q3 2025, BioNexus Gene Lab's Exchange Rate Effect is $28535.0, which was down 9495.24% from $215220.0 recorded in Q2 2025.
  • BioNexus Gene Lab's Exchange Rate Effect's 5-year high stood at $565319.0 during Q3 2024, with a 5-year trough of -$409601.0 in Q4 2024.
  • For the 5-year period, BioNexus Gene Lab's Exchange Rate Effect averaged around -$9343.2, with its median value being -$33517.0 (2021).
  • Per our database at Business Quant, BioNexus Gene Lab's Exchange Rate Effect surged by 96612.76% in 2022 and then plummeted by 97152.86% in 2024.
  • Quarter analysis of 5 years shows BioNexus Gene Lab's Exchange Rate Effect stood at $21764.0 in 2021, then skyrocketed by 966.13% to $232032.0 in 2022, then tumbled by 79.75% to $46998.0 in 2023, then plummeted by 971.53% to -$409601.0 in 2024, then soared by 106.97% to $28535.0 in 2025.
  • Its Exchange Rate Effect stands at $28535.0 for Q3 2025, versus $215220.0 for Q2 2025 and $43050.0 for Q1 2025.